Güllü I - Search Results

1

Dramatic response to ifosfamide, mesna and doxorubicin chemotherapy regimen in an adult with clear cell sarcoma of the kidney.

Yalçin S, Barişta I, Tekuzman G, Güllü I, Firat D. Yalçin S, et al. Among authors: gullu i. J Urol. 1996 Jun;155(6):2024. J Urol. 1996. PMID: 8618315 No abstract available.

2

Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer.

Kiraz S, Baltali E, Güler N, Barista I, Benekli M, Celik I, Güllü IH, Kars A, Tekuzman G, Firat D. Kiraz S, et al. Among authors: gullu ih. J Chemother. 1996 Aug;8(4):310-4. doi: 10.1179/joc.1996.8.4.310. J Chemother. 1996. PMID: 8873839 Clinical Trial.

3

Ifosfamide-based chemotherapy for recurrent or metastatic hemangiopericytoma.

Celik I, Başçil N, Yalçin S, Güllü IH, Kars A, Barişta I, Tekuzman G. Celik I, et al. Among authors: gullu ih. Acta Oncol. 1997;36(3):348. doi: 10.3109/02841869709001277. Acta Oncol. 1997. PMID: 9208911 No abstract available.

4

Ifosfamide and etoposide in previously treated patients with advanced breast cancer.

Kiraz S, Baltali E, Güler N, Barişta I, Benekli M, Celik I, Güllü IH, Kars A, Tekuzman G, Firat D. Kiraz S, et al. Among authors: gullu ih. Tumori. 1997 Mar-Apr;83(2):604-7. doi: 10.1177/030089169708300225. Tumori. 1997. PMID: 9226029

5

Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy.

Yalçin S, Güllü I, Barişta I, Tekuzman G, Ozişik Y, Celik I, Kars A. Yalçin S, et al. Among authors: gullu i. Cancer Invest. 1998;16(5):297-302. doi: 10.3109/07357909809084647. Cancer Invest. 1998. PMID: 9627675 Clinical Trial.

6

VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomas.

Yalçin S, Kars A, Ozişik Y, Tekuzman G, Ozyilkan O, Celik I, Barişta I, Güllü I, Güler N, Baltali E, Firat D. Yalçin S, et al. Among authors: gullu i. Eur J Haematol. 1998 Oct;61(4):261-5. doi: 10.1111/j.1600-0609.1998.tb01712.x. Eur J Haematol. 1998. PMID: 9820633 Clinical Trial.

7

Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.

Barişta I, Tekuzman G, Yalçin S, Güllü I, Güler N, Ozişik Y, Kars A, Celik I, Türker A, Altundağ K, Zengin N, Uner A, Baltali E, Firat D. Barişta I, et al. Among authors: gullu i. J Surg Oncol. 2000 Jan;73(1):12-6. J Surg Oncol. 2000. PMID: 10649272

8

High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas.

Güllü I, Yalçin S, Tekuzman G, Barişta I, Alkiş N, Celik I, Zengin N, Güler N, Kars A, Baltali E, et al. Güllü I, et al. Cancer Invest. 1996;14(3):239-42. doi: 10.3109/07357909609012146. Cancer Invest. 1996. PMID: 8630686

9

Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer.

Yalcin S, Oksuzoglu B, Tekuzman G, Engin H, Celik I, Turker A, Barista I, Gullu I, Guler N, Altundag K, Ozisik Y, Kars A. Yalcin S, et al. Among authors: gullu i. Jpn J Clin Oncol. 2003 Nov;33(11):580-3. doi: 10.1093/jjco/hyg111. Jpn J Clin Oncol. 2003. PMID: 14711983

10

Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.

Yildiz F, Zengin N, Engin H, Güllü I, Barista I, Caglar M, Ozyar E, Cengiz M, Gürkaynak M, Zorlu F, Caner B, Atahan IL, Tekuzman G. Yildiz F, et al. Among authors: gullu i. Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):839-46. doi: 10.1016/j.ijrobp.2004.04.002. Int J Radiat Oncol Biol Phys. 2004. PMID: 15465201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters